Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...

The genetic modification therapy market presents key opportunities in developing specialized treatments for rare, inherited, ...

Researchers explored a novel strategy involving CRISPR–Cas3 and investigated its potential using a mouse model of ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today announced the appointment of Venkat R. Krishnamurthy, Ph.D., as Chief Scientific Officer. Dr.

Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism.

A research team led by Associate Professor Hirofumi Nishizono and graduate student Masaki Kato from the Research Support ...

Therapeutic Potential of CRISPR–Cas3 Genome-Editing System for Transthyretin Amyloidosis. Credit: Institute of Medical ...

CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations ...

Learn more about whether Perrigo Company plc or Wave Life Sciences Ltd. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Adenosine deaminase acting on RNA (ADAR) is the enzyme responsible for adenosine-to-inosine (A-to-I) RNA editing, a process ...

Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and ...